Skip to content
Clinical Trials – home
Medical University Of Warsaw
Sponsor

Medical University Of Warsaw

Poland Ul. Zwirki I Wigury 61, 02-091 Warsaw, Poland

About the sponsor

Research activity includes treatment strategies for relapsed or resistant B-cell acute lymphoblastic leukemia with measurable residual disease and light chain amyloidosis, with interest in immune-based and supportive approaches for marrow and organ involvement.

  • Anti-CD19 CAR T-cell therapy
  • Immunochemotherapy in amyloidosis
  • Organ response in amyloid disease

The sponsor also supports studies in myelosuppression and hematologic recovery linked to complex cancer care.

About Specializations

Medical University Of Warsaw runs clinical trials in conditions such as Peripheral arterial occlusive disease, Diabetic foot, IgA nephropathy, Neurofibromatosis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

12 clinical trials

Study on the Safety of Leukocyte-Platelet Rich Fibrin for Patients with Critical Limb Ischemia

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Fibrin
  • Sponsor:Medical University Of Warsaw

Diabetic foot

Recruiting

Study on the Safety and Effectiveness of Allogenic Stem Cells for Treating Diabetic Foot Ulcers in Patients with Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Medical University Of Warsaw

IgA nephropathy

Recruiting

Study on the Effectiveness and Safety of Budesonide and Prednisone for Children with Primary IgA Nephropathy

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Budesonide
  • Sponsor:Medical University Of Warsaw

Study on Crizotinib for Treating Severe Neurofibromatosis Type 2 in Children Not Eligible for Surgery or Radiotherapy

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Crizotinib
  • Sponsor:Medical University Of Warsaw

Study of Tisagenlecleucel for Treating Adult Patients with Resistant or Relapsed B-cell Acute Lymphoblastic Leukemia

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tisagenlecleucel
  • Sponsor:Medical University Of Warsaw

Study on Persistent Pulmonary Hypertension in Newborns Treated with Salbutamol and Sodium Chloride

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Salbutamol Sulfate
  • Sponsor:Medical University Of Warsaw
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Budesonide
  • Sponsor:Medical University Of Warsaw

Primary amyloidosis

Not recruiting

Study on the Safety and Effectiveness of Sargramostim with Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone in Untreated Light Chain Amyloidosis Patients

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Medical University Of Warsaw

Cardiac failure acute

Not recruiting

Study on Empagliflozin and Dapagliflozin for Patients Hospitalized with Acute Heart Failure

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Dapagliflozin
  • Sponsor:Medical University Of Warsaw

Hypertension

Not recruiting

Study on the Effectiveness and Safety of Nebivolol for Treating High Blood Pressure in Adolescents

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Nebivolol Hydrochloride
  • Sponsor:Medical University Of Warsaw

Evaluation of fenofibrate treatment on beta cell function in children and adolescents newly diagnosed with type 1 diabetes

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Fenofibrate Micronised
  • Sponsor:Medical University Of Warsaw

Myocarditis

Not recruiting

Study of prednisone and azathioprine treatment in patients with virus-negative myocarditis or inflammatory heart muscle disease with reduced heart pump function

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Medical University Of Warsaw

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.